DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "Global Autoimmune and Inflammatory Immunomodulators Market 2016-2020" report to their offering.
The global autoimmune and inflammatory immunomodulators market to grow at a CAGR of 7.01% during the period 2016-2020.
The report covers the present scenario and the growth prospects of the global autoimmune and inflammatory immunomodulators market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of drugs that are expected to be launched into the market along with the decline in revenues from the patent expiries of the marketed drugs during the forecast period. The report also includes a discussion of the key vendors operating in this market.
Immunomodulators are the drugs that help to regulate the immune system. These drugs either stimulate the weak immune systems or moderate the overactive immune systems. Though many drugs are available in the market, there still exists a huge unmet need in the autoimmune and inflammatory immunomodulators market as there are no medicines that provide complete cure to some diseases such as rheumatoid arthritis, ulcerative colitis, and Crohn's disease.
Key vendors
- AbbVie
- Johnson & Johnson
- Amgen
- F. Hoffmann-La Roche
- Pfizer
Other prominent vendors
- AstraZeneca
- Avaxia Biologics
- Biogen Idec
- Bristol-Myers Squibb
- Boehringer Ingelheim
- Eli Lilly
- Enlivex Therapeutics
- Gilead Sciences
- Immune Pharmaceuticals
- Merck
- Mitsubishi Tanabe Pharma
- Neovacs
- Prometheus Laboratories
- Sandoz
- Sanofi
- Swedish Orphan Biovitrum
- Takeda Pharmaceuticals
- UCB
Key Topics Covered:
Part 01: Executive summary
Part 02: Scope of the report
Part 03: Market research methodology
Part 04: Introduction
Part 05: Autoimmune and inflammatory diseases
Part 06: Pipeline portfolio
Part 07: Market landscape
Part 08: Market segmentation by type of disease
Part 09: Market segmentation by molecule type
Part 10: Geographical segmentation
Part 11: Market drivers
Part 12: Impact of drivers
Part 13: Market challenges
Part 14: Impact of drivers and challenges
Part 15: Market trends
Part 16: Vendor landscape
Part 17: Key vendor analysis
Part 18: Appendix
For more information about this report visit http://www.researchandmarkets.com/research/6z2mv3/global_autoimmune
